Home » Management Articles » Skila Sponsoring at Pharma Marketing Excellence Europe 2011
Skila Sponsoring at Pharma Marketing Excellence Europe 2011
Skila, a provider of fully managed SaaS product launch and KOL management to life science companies, is a sponsor and exhibitor at Pharma Marketing Europe 2011 to showcase iLaunch, Skila's unique solution to optimize control over product launches.
MORRIS PLAINS, NJ, October 23, 2011 /Management PR News/ -- Skila, a leading provider of fully managed "Solution" as-a-Service (SaaS) product launch management and key opinion leader (KOL) management to pharmaceutical and medical device companies, has announced today that they are a gold sponsor and will be exhibiting at the 11th Annual Pharma Marketing Europe 2011 in Berlin, Germany on November 22 and 23. Eyeforpharma's Pharma Marketing conference is Europe's flagship Marketing and Brand Excellence Summit. The conference will discuss how to engage stakeholders and maximize brand potential.
Skila's President and Chief Operating Office, Simon Mason, believes that Pharma Marketing Europe is the perfect venue for showcasing iLaunch, Skila's unique solution to optimizing control over product launches.
Mr. Mason states, "Skila offers a fully-managed approach that addresses complex pharmaceutical commercial workflow challenges. The Skila Lifecycle Platform was custom developed exclusively for the life science industry and enables faster decision making around product launch processes. The iLaunch solution is specially designed to help clients achieve a successful launch with features such as the 360 Launch Readiness Module that transforms commercialization and implementation plans into vibrant, interactive displays with interdependencies, dynamically updated reporting and rules-driven alerts and notifications. Additional modules include critical path timelines, launch sequencing, team collaboration, product knowledgebase and post-launch tracking - all within a single-touchpoint. "
Mr. Mason goes on to explain "Many companies say their products are different; Skila solutions truly are different. We work with clients to deliver the value of the iLaunch solution right to their inbox or on their mobile devices. The Skila solutions are easy to implement, use and manage with an enterprise back-end. We have a unique Intelligration Engine technology that provides a vertical approach for teams, regions, countries or brands with views and visualizations tailored to the needs of each. The Skila Lifecycle Platform with its modular approach to implementation makes integration with existing client systems seamless. Our solution content is accessible via a web browser, mobile device and email, and supports current workflows with minimal disruption."
Skila is the only knowledge-enabled solutions provider with Intelligration - the intelligent integration of people, processes and information.
About Skila
Skila, a BelHealth investment company, is a global technology and services company specializing in fully managed "Solution" as-a-Service (SaaS) product launch lifecycle management and engagement / relationship management solutions for the healthcare industry. Skila's solutions address the broad needs of global marketing, medical, market access, executive and alliance management teams that include a unique methodology, robust technology and key continuous services for effectively managing global product launches, key opinion leader relationships, market access / managed care, business performance, competitive intelligence, and key partnerships and alliances.
Having developed strong relationships with a broad number of global pharmaceutical companies, Skila's solutions have been deployed in 61 countries, supporting numerous global brands and more than 10 million user interactions. Skila's long-standing commitment and understanding of customers' needs has resulted in the exponential growth and adoption of our methodology, technology and continuous services as the business platform of choice for our clients.
About BelHealth Investment Partners
BelHealth Investment Partners L.P. ("BelHealth") is a private equity buyout fund focused exclusively on the small-cap healthcare industry. BelHealth acquires majority positions in healthcare companies that the BelHealth Team believes are undervalued or undermanaged and would benefit from the vast entrepreneurial and operating experience that BelHealth can deliver. Applying an active, hands-on approach to governance, BelHealth utilizes its experience to drive revenue and profit growth and achieve superior returns for its investors. For more information about BelHealth, please visit: www.BelHealth.com.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com |
|
|
Press Release Contact Information:
Elaine Nowak
Skila
Head of Product Marketing
201 Littleton Rd
Morris Plains, NJ
USA 07950
Voice: 973-889-1300
Fax: 973-889-5455
Website: Visit Our Website |
|
|
|
|
| MANAGEMENT ARCHIVE SEARCH |
|
|
| |
|
|
Advertise With Us |
About Us |
Contact Us